US 6592872
Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
expired A61KA61K39/00
Quick answer
US patent 6592872 (Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K39/00